Difficulty: Medium
Average Score: 89%
Practice
Which of the following drugs is least likely to be prescribed to patients with prostatic hypertrophy, glaucoma, coronary and cerebrovascular disease?
Correct answer
A
Rationale
In the context of pharmacological lifespan treatment, the correct answer is A) Amitriptyline. This drug is a tricyclic antidepressant that has anticholinergic effects, which can exacerbate conditions like prostatic hypertrophy, glaucoma, coronary, and cerebrovascular disease.
Paroxetine and fluoxetine (options B and D) are selective serotonin reuptake inhibitors (SSRIs), which are generally safer choices for patients with the listed conditions compared to tricyclic antidepressants like amitriptyline. Bupropion (option C) is a norepinephrine-dopamine reuptake inhibitor and may also be considered a safer option in these cases due to its different mechanism of action and lower anticholinergic effects.
In an educational context, understanding the pharmacological profiles of different drug classes is crucial for making appropriate treatment decisions based on a patient's comorbidities. This question highlights the importance of considering not only the primary indication for a drug but also its potential side effects and contraindications in specific patient populations.
Paroxetine and fluoxetine (options B and D) are selective serotonin reuptake inhibitors (SSRIs), which are generally safer choices for patients with the listed conditions compared to tricyclic antidepressants like amitriptyline. Bupropion (option C) is a norepinephrine-dopamine reuptake inhibitor and may also be considered a safer option in these cases due to its different mechanism of action and lower anticholinergic effects.
In an educational context, understanding the pharmacological profiles of different drug classes is crucial for making appropriate treatment decisions based on a patient's comorbidities. This question highlights the importance of considering not only the primary indication for a drug but also its potential side effects and contraindications in specific patient populations.